Home Hetero 2904

Hetero 2904

APLICATIONS

New Drug Approval

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

Harish Chawla - June 22, 2023 0

VYVGART® Hytrulo is the first FDA-approved subcutaneous (SC) injectable for generalized myasthenia gravis (gMG) SAN DIEGO, June 20, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme")...

DCR Analysis – Job of Area Manager

April 4, 2020

Interview Questions – Area Manager in Pharmaceutical Companies

April 22, 2020

Leaves – Types and Details

April 16, 2020

HOT NEWS

New Drug Approval

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

News & Articles

Heat Stroke | Rising Temperature | Tips to Prevent Heat Stroke

Role and Responsibilities

Detailing – Sales Presentation – An art of Effective Communication

Learning and Development